颈动脉内膜剥脱术中ACUSEAL聚四氟乙烯补片与心包补片的前瞻性随机试验长期耐久性与临床结局比较
本前瞻性随机试验将200例颈动脉内膜剥脱术按1:1随机分配至ACUSEAL补片组或心包补片组,平均随访80个月(范围0-149个月),比较远期临床结局。10年时两组免于卒中、免于卒中/死亡及总生存率均无显著差异,但ACUSEAL补片组免于≥50%再狭窄率显著更优(P = .0489),≥80%再狭窄率无显著差异(P = .9407)。结论认为两种补片均耐久且10年临床结局相似,除ACUSEAL补片在免于≥50%再狭窄方面显著更好。
要点
- 10年免于卒中率ACUSEAL组93% vs 心包补片组92%(P = .1112),无显著差异。
- 10年免于≥50%再狭窄率ACUSEAL组79% vs 心包补片组71%(P = .0489),ACUSEAL显著更优。
- 10年免于≥80%再狭窄率ACUSEAL组85% vs 心包补片组93%(P = .9407),无显著差异。
核心结论
- ACUSEAL聚四氟乙烯补片与心包补片在颈动脉内膜剥脱术中均耐久,10年临床结局相似,但ACUSEAL补片免于≥50%再狭窄率显著更优。
研究设计与样本
- 前瞻性随机试验,共200例颈动脉内膜剥脱术按1:1随机分配至Vascu-Guard心包补片组或ACUSEAL补片组。
- 所有患者术后即刻行双功能超声检查,并于6个月及此后每年重复。
- 采用Kaplan-Meier分析估计免于卒中率、无卒中生存率及免于≥50%和≥80%再狭窄率。
主要发现
- 平均随访80个月(范围0-149个月),总体人口学和临床特征大致相似。
- 1、2、3、5、10年免于卒中率ACUSEAL组分别为97%、97%、97%、96%、93%,心包补片组分别为99%、98%、97%、97%、92%(P = .1112)。
- 1、2、3、5、10年免于卒中/死亡率ACUSEAL组分别为94%、93%、90%、76%、50%,心包补片组分别为99%、96%、91%、78%、47%(P = .8591)。
- 1、2、3、5、10年免于≥50%再狭窄率ACUSEAL组分别为98%、98%、96%、89%、79%,心包补片组分别为87%、83%、83%、81%、71%(P = .0489)。
- 1、2、3、5、10年免于≥80%再狭窄率ACUSEAL组分别为99%、99%、99%、96%、85%,心包补片组分别为96%、96%、96%、93%、93%(P = .9407);总生存率ACUSEAL组分别为95%、94%、91%、77%、51%,心包补片组分别为100%、98%、93%、79%、50%(P = .9123)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Several studies have shown the superiority of carotid endarterectomy (CEA) with patch closure over primary closure. However, no definite study has shown any significant differences in clinical outcome between various types of patches. Because more vascular surgeons have used pericardial patching recently, this study will analyze the late clinical outcome (≥10 years) of our previously reported prospective randomized trial comparing CEA with ACUSEAL (polytetrafluoroethylene) vs pericardial patching. METHODS: A total of 200 CEAs were randomized (1:1) to either Vascu-Guard pericardial patching or ACUSEAL patching. All patients had immediate duplex ultrasound imaging, which was repeated at 6 months and annually thereafter. Kaplan-Meier analysis was used to estimate rates of freedom from stroke, stroke-free survival, and rates of freedom from ≥50% and ≥80% restenosis. RESULTS: Overall demographic and clinical characteristics were somewhat similar with a mean follow-up of 80 months (range: 0-149 months). The rates of freedom from stroke were 97, 97, 97, 96, 93 for ACUSEAL vs 99, 98, 97, 97, 92 for pericardial patching (P = .1112) at 1, 2, 3, 5, and 10 years, respectively. Similarly, the rates of freedom from stroke/death were 94, 93, 90, 76, 50 for ACUSEAL vs 99, 96, 91, 78, 47 for pericardial patching (P = .8591). The rates of freedom from ≥50% restenosis were 98, 98, 96, 89, 79 for ACUSEAL vs 87, 83, 83, 81, 71 for pericardial patching (P = .0489). The rates of freedom from ≥80% restenosis were 99, 99, 99, 96, 85 for ACUSEAL vs 96, 96, 96, 93, 93 for pericardial patching (P = .9407). The overall survival rates were 95, 94, 91, 77, 51 for ACUSEAL vs 100, 98, 93, 79, 50 for pericardial patching (P = .9123). Other patch complications (eg, rupture, aneurysmal dilation, infection, etc) were similar. CONCLUSIONS: Both CEA with ACUSEAL (polytetrafluoroethylene) and pericardial patching are durable and have similar clinical outcomes at 10 years except that ACUSEAL patching has significantly better rates of freedom from ≥50% restenosis.
引用
- AbuRahma Z, Williams E, Lee A, et al. Long-term durability and clinical outcome of a prospective randomized trial comparing carotid endarterectomy with ACUSEAL polytetrafluoroethylene patching versus pericardial patching. J Vasc Surg. 2023. PMID: 36958535. doi:10.1016/j.jvs.2023.01.189
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。